The GHA mouse, transgenic for a GHRA and with reduced IGF1, mimics a pharmacologic inhibition of GHR and provides an excellent model to assess the effects of multiple chemotherapeutic efficacies in presence of a GHRA for multiple cancer types. Here, IGF1 is linked to cancer.